Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP484812.RAp_FkxJ0A78zM-wRkJhOUCnjoiCs_52yA5Mtf7LJdrzY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP484812.RAp_FkxJ0A78zM-wRkJhOUCnjoiCs_52yA5Mtf7LJdrzY130_assertion type Assertion NP484812.RAp_FkxJ0A78zM-wRkJhOUCnjoiCs_52yA5Mtf7LJdrzY130_head.
- NP484812.RAp_FkxJ0A78zM-wRkJhOUCnjoiCs_52yA5Mtf7LJdrzY130_assertion description "[We carried out a gene expression profiling study using cDNA array technology with 24 primary glioma tissues of low-grade (oligodendroglioma), intermediate-grade (anaplastic oligodendroglioma and anaplastic astrocytoma), and high-grade (glioblastomas multiforme) tumors and found that insulin-like growth factor binding protein 2 (IGFBP2) was consistently overexpressed only in glioblastoma multiforme.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484812.RAp_FkxJ0A78zM-wRkJhOUCnjoiCs_52yA5Mtf7LJdrzY130_provenance.
- NP484812.RAp_FkxJ0A78zM-wRkJhOUCnjoiCs_52yA5Mtf7LJdrzY130_assertion evidence source_evidence_literature NP484812.RAp_FkxJ0A78zM-wRkJhOUCnjoiCs_52yA5Mtf7LJdrzY130_provenance.
- NP484812.RAp_FkxJ0A78zM-wRkJhOUCnjoiCs_52yA5Mtf7LJdrzY130_assertion SIO_000772 10485462 NP484812.RAp_FkxJ0A78zM-wRkJhOUCnjoiCs_52yA5Mtf7LJdrzY130_provenance.
- NP484812.RAp_FkxJ0A78zM-wRkJhOUCnjoiCs_52yA5Mtf7LJdrzY130_assertion wasDerivedFrom befree-20150227 NP484812.RAp_FkxJ0A78zM-wRkJhOUCnjoiCs_52yA5Mtf7LJdrzY130_provenance.
- NP484812.RAp_FkxJ0A78zM-wRkJhOUCnjoiCs_52yA5Mtf7LJdrzY130_assertion wasGeneratedBy ECO_0000203 NP484812.RAp_FkxJ0A78zM-wRkJhOUCnjoiCs_52yA5Mtf7LJdrzY130_provenance.